0:00
24:10
The FDA's rejection of MDMA as a treatment may well be a short-term setback for legally helping people with PTSD and other disorders. Mason Marks of Harvard Law School’s Petrie-Flom Center for Health Law Policy offers his assessment.
Hosted on Acast. See acast.com/privacy for more information.
D'autres épisodes de "Cato Daily Podcast"
Ne ratez aucun épisode de “Cato Daily Podcast” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.